Worth reading
71In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
424
¥100 million (year-on-year increase in net sales)Wording
Avoiding a definitive answer
How definitive the wording is.Contents of this document
Earnings presentationFY2026 First Quarter9 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥2,797 million+18.0%
Operating profit¥170 million+66.0%
Ordinary income¥180 million+69.0%
Net income¥146 million+95.0%
Gross Profit Margin19.7%
Operating profit margin6.1%
Selling, general and administrative expenses¥381 million
Results for the three months of the current quarter
Net Sales
¥2,797 million
Gross profit
¥551 million
Operating profit
¥170 million
Ordinary income
¥180 million
Net income
¥146 million
Full-year earnings forecast
Net Sales
¥10,000 million
Gross profit
¥1,980 million
Selling, general and administrative expenses
¥1,530 million
Operating profit
¥450 million
Ordinary income
¥450 million
Net income
¥345 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales28%
Gross profit28%
Selling, general and administrative expenses25%
Operating profit38%
Ordinary income40%
Net income42%
Materials revenue28%
Materials gross profit29%
Materials operating profit42%
Electronics net sales28%
Electronics gross profit27%
Electronics operating profit34%
Life Sciences revenue27%
Life Sciences gross profit27%
Life Sciences operating profit40%
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Foreign exchange impact (gross profit)+¥2.5 billion
- Foreign exchange impact (operating profit)+¥900 million
- Decrease in operating cash flow due to an increase in working capital¥30.6 billion
- Investing cash outflow for the acquisition of property, plant and equipment¥3.4 billion
- Decrease in retirement benefit expenses related to the amortization of actuarial differences¥900 million year-on-year increase in operating profit (Other and Corporate)
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
US$ exchange rate (period average)¥155.0
RMB exchange rate (period average)¥22.5
Foreign exchange sensitivityA ¥1 depreciation of the US$ increases operating profit by approximately ¥50 million; a ¥1 depreciation of the RMB increases operating profit by approximately ¥400 million
New initiatives
- Expansion of sales of modified epoxy resins for AI semiconductors
- Start of small-scale mass production of a-SMC as an encapsulant for high-performance IC package substrates for advanced semiconductors
- Resolution in August 2026 to acquire ¥3 billion of treasury shares
- Inventory control in preparation for price declines caused by the situation in the Middle East
Key KPIsA metric the company considers important as a management benchmark.
- US$ exchange rate (period average)¥159.5Year on year against the same period last year¥14.9 weaker
- RMB exchange rate (period average)¥23.4Year on year against the same period last year¥3.4 weaker
- Equity ratio47.4%
- NET D/E ratio0.39 times
Segment results
Materials
Net Sales
¥1,403 million+18.0%
Gross profit
¥228 million+26.0%
Operating profit
¥81 million+63.0%
Electronics
Net Sales
¥491 million+18.0%
Gross profit
¥127 million+23.0%
Operating profit
¥49 million+60.0%
Life Science
Net Sales
¥902 million+17.0%
Gross profit
¥195 million+24.0%
Operating profit
¥29 million+37.0%
Financial targets
Equity ratio of 47.4%, NET D/E ratio of 0.39 (target value: not disclosed)Capital expenditures
¥46 100 million capital expenditures
Annual Dividend
Annual¥27
Interim¥13
End of period¥14
Acquisition of treasury shares
¥3 billion
PeriodPlanned for 5 August to 30 September 2026
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | FY2026 First Quarter |
| Net Sales | ¥2,797 million (YoY +18.0%) |
| Operating profit | ¥170 million (YoY +66.0%) |
| Ordinary income | ¥180 million (YoY +69.0%) |
| Net income | ¥146 million (YoY +95.0%) |
| Gross Profit Margin | 19.7% |
| Operating profit margin | 6.1% |
| Selling, general and administrative expenses | ¥381 million |
| Results for the three months of the current quarter | Net Sales ¥2,797 million / Gross profit ¥551 million / Operating profit ¥170 million / Ordinary income ¥180 million / Net income ¥146 million |
| Full-year earnings forecast | Net Sales ¥10,000 million / Gross profit ¥1,980 million / Selling, general and administrative expenses ¥1,530 million / Operating profit ¥450 million / Ordinary income ¥450 million / Net income ¥345 million |
| Progress against full-year forecast | Net Sales 28% / Gross profit 28% / Selling, general and administrative expenses 25% / Operating profit 38% / Ordinary income 40% / Net income 42% / Materials revenue 28% / Materials gross profit 29% / Materials operating profit 42% / Electronics net sales 28% / Electronics gross profit 27% / Electronics operating profit 34% / Life Sciences revenue 27% / Life Sciences gross profit 27% / Life Sciences operating profit 40% |
| Segment results | Materials Net Sales ¥1,403 million (YoY +18.0%) / Gross profit ¥228 million (YoY +26.0%) / Operating profit ¥81 million (YoY +63.0%) / Electronics Net Sales ¥491 million (YoY +18.0%) / Gross profit ¥127 million (YoY +23.0%) / Operating profit ¥49 million (YoY +60.0%) / Life Science Net Sales ¥902 million (YoY +17.0%) / Gross profit ¥195 million (YoY +24.0%) / Operating profit ¥29 million (YoY +37.0%) |
| Breakdown of Factors Affecting the Change | Factors Foreign exchange impact (gross profit) / Amount +¥2.5 billion, Factors Foreign exchange impact (operating profit) / Amount +¥900 million, Factors Decrease in operating cash flow due to an increase in working capital / Amount ¥30.6 billion, Factors Investing cash outflow for the acquisition of property, plant and equipment / Amount ¥3.4 billion, Factors Decrease in retirement benefit expenses related to the amortization of actuarial differences / Amount ¥900 million year-on-year increase in operating profit (Other and Corporate) |
| Key KPIs | Indicator name US$ exchange rate (period average) / Value ¥159.5 / Year on year against the same period last year ¥14.9 weaker, Indicator name RMB exchange rate (period average) / Value ¥23.4 / Year on year against the same period last year ¥3.4 weaker, Indicator name Equity ratio / Value 47.4% / Year on year against the same period last year Not disclosed, Indicator name NET D/E ratio / Value 0.39 times / Year on year against the same period last year Not disclosed |
| Assumptions Underlying the Business Outlook | US$ exchange rate (period average) ¥155.0 / RMB exchange rate (period average) ¥22.5 / Foreign exchange sensitivity A ¥1 depreciation of the US$ increases operating profit by approximately ¥50 million; a ¥1 depreciation of the RMB increases operating profit by approximately ¥400 million |
| Financial targets | Equity ratio of 47.4%, NET D/E ratio of 0.39 (target value: not disclosed) |
| Annual Dividend | Annual ¥27 / Interim ¥13 / End of period ¥14 |
| Acquisition of treasury shares | Amount ¥3 billion / Number of Shares Not disclosed / Period Planned for 5 August to 30 September 2026 |
| Capital expenditures | ¥46 100 million (capital expenditures) |
| New initiatives | Expansion of sales of modified epoxy resins for AI semiconductors, Start of small-scale mass production of a-SMC as an encapsulant for high-performance IC package substrates for advanced semiconductors, Resolution in August 2026 to acquire ¥3 billion of treasury shares, Inventory control in preparation for price declines caused by the situation in the Middle East |
Items this document does not state (10)
Self-assessment against the planUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsPayout ratioOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This was due to business expansion, the company’s reliable response to customer requirements amid supply chain disruptions caused by the situation in the Middle East, and strong performance in areas including surging market prices, customer demand for contingency measures, modified epoxy resins for AI semiconductors, and the Solutions business of the Prinova Group.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.